# US 2001/0026916 A1 · Diagnostic methods for alzheimer's disease by detection of multiple mrnas

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0026916 A1
- Document ID: US20010026916A1
- Status: Published application
- Kind: A1
- Application number: 09/183,636
- Filed: 1998-10-30
- Published: 2001-10-04
- Earliest claimed: 1998-10-30
- Assignees: The Trustees of the University of Pennsylvania
- Inventors: STEPHEN GINSBERG; JOHN Q. TROJANOWSKI; VIRGINIA M.-Y. LEE; JAMES EBERWINE
- Web page: https://patentgrep.com/patent/US20010026916A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods of detecting RNA in brain tissue of patients with Alzheimer's disease are provided. Methods of diagnosing Alzheimer's disease by detection of these RNAs are also provided.

## Claims

### Claim 1

A method of identifying senile plaques, neurofibrillary tangles and neuropil threads in brain tissue comprising:
(a) contacting brain tissue with a fluorescent dye capable of intercalating selectively into nucleic acids; and
(b) detecting any fluorescence in the brain tissue indicative of senile plaques, neurofibrillary tangles and neuropil threads in the brain tissue.

### Claim 2

A method of identifying RNAs in senile plaques, neurofibrillary tangles, and neuropil threads of brain tissue which encode proteins involved in the pathogenesis of Alzheimer's disease comprising:
(a) isolating single senile plaques in brain tissue by immunocytochemical techniques;
(b) identifying the presence of RNA by contacting said senile plaque with a fluorescent dye capable of intercalating selectively into nucleic acids;
(c) amplifying the identified RNA; and
(d) determining whether the amplified RNA product hybridizes to any known cDNAs for proteins involved in the pathogenesis of Alzheimer's disease.

### Claim 3 (depends on 2)

A method of diagnosing Alzheimer's disease in a patient suspected of having Alzheimer's disease comprising detecting the presence of an RNA identified by the method of claim 2 in the brain of the patient.

### Claim 4

A method of detecting the presence of messenger RNA in senile plaques, neurofibrillary tangles, and neuropil threads of brain tissue wherein said messenger RNA encodes a protein involved in the pathogenesis of Alzheimer's disease comprising:
a) isolating single senile plaques in brain tissue by immunocytochemical methods;
b) identifying the presence of RNA by contacting said senile plaque with a fluorescent dye capable of intercalating selectively into nucleic acids;
c) amplifying said RNA; and
d) hybridizing the amplified RNA product to a known cDNA for a protein involved in the pathogenesis of Alzheimer's disease.
